The last few months have had some challenging outcomes Alzheimer’s research. Scientists at the Merck, a American pharmaceutical company, recently announced that they were ending the trials for their latest Alzheimer’s drug after results were proving to be ineffective. There were in the midst of Phase 2 and 3 EPOCH trial of verubecestat as a...
Read More